Renal diseases in cystic fibrosis;Mucoviscidose et rein

Nephrologie et Therapeutique

Volumn 5, Issue 6, 2009, Pages 550-558

  Montagnac, Richard ^a   Sanlaville, Fabienne ^a   Soto, Bertrand ^a   Vuiblet, Vincent ^b   Schillinger, Francis ^a  

^a CENTRE HOSPITALIER DE TROYES   (France)

^b REIMS UNIVERSITY HOSPITAL   (France)

Author keywords

Aminoglycoside nephrotoxicity; Cystic fibrosis; Diabetes mellitus; IgA nephropathy; Renal failure; Urolithiasis

Indexed keywords

ANTIBIOTIC AGENT;

ADULT; ARTICLE; BACTERIAL INFECTION; CASE REPORT; CYSTIC FIBROSIS; DIABETES MELLITUS; DISEASE ASSOCIATION; EXPOSURE; GLOMERULONEPHRITIS; HUMAN; IMMUNE COMPLEX DISEASE; IMMUNOGLOBULIN A NEPHROPATHY; KIDNEY DISEASE; KIDNEY FAILURE; LIFE EXPECTANCY; NEPHROLITHIASIS; NEPHROTOXICITY; PATIENT MONITORING; RISK FACTOR;

ADULT; CYSTIC FIBROSIS; GLOMERULONEPHRITIS, IGA; HUMANS; MALE;

EID: 71249127544     PISSN: 17697255     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nephro.2009.05.005     Document Type: Article

References (117)

1. Stanton B.A. Cystic fibrosis transmembrane conductance regulator (CFTR) and renal function. Wien Klin Wochenschr 12-13 (1997) 457-464
2. Morales M.M., Falkenstein D., and Lopes A.G. The cystic fibrosis transmembrane regulator (CFTR) in the kidney. An Acad Bras Cienc 3 (2000) 399-406
3. Lester L.A., Kraut J., Lloyd-Still J., Karrison T., Mott C., Billstrand C., et al. Delta F508 genotype does not predict disease severity in an ethnically diverse cystic fibrosis population. Pediatrics 1 (1994) 114-118
4. Navarro H., Kolbach M., Repetto G., Guiraldes E., Harris P., Foradori A., et al. Correlation between phenotype and genotype in a group of patients with cystic fibrosis. Rev Med Chil 5 (2002) 475-481
5. Beckerman R.C., and Taussig L.M. Hypoelectrolytemia and metabolic alkalosis in infants with cystic fibrosis. Pediatrics 4 (1979) 580-583
6. Bates C.M., Baum M., and Quigley R. Cystic fibrosis presenting with hypokalemia and metabolic alkalosis in a previously healthy adolescent. J Am Soc Nephrol 2 (1997) 352-355
7. Bar-Or O., Blimkie C.J., Hay J.A., MacDougall J.D., Ward D.S., and Wilson W.M. Voluntary dehydration and heat intolerance in cystic fibrosis. Lancet 8795 (1992) 696-699
8. Davé S., Honney S., Raymond J., and Flume P.A. An unusual presentation of cystic fibrosis in an adult. Am J Kidney Dis 3 (2005) e41-e44
9. Desmazes-Dufeu N., Hubert D., Burgel P.R., Kanaan R., Vélea V., and Dusser D. Severe dehydration and August 2003 heat wave in a cohort of adults with cystic fibrosis. Presse Med 9 (2005) 647-648
10. Augusto J.F., Sayegh J., Malinge M.C., Illouz F., Subra J.F., and Ducluzeau P.H. Severe episodes of extracellular dehydration: an atypical adult presentation of cystic fibrosis. Clin Nephrol 4 (2008) 302-305
11. Stephens S.E., and Rigden S.P. Cystic fibrosis and renal disease. Paediatr Respir Rev 2 (2002) 135-138
12. Mukherjee R., Whitehouse J., and Honeybourne D. Renal impairment in cystic fibrosis. Thorax 5 (2008) 473
13. Abramowsky C.R., and Swinehart G.L. The nephropathy of cystic fibrosis: a human model of chronic nephrotoxicity. Hum Pathol 10 (1982) 934-939
14. Davis C.A., Abramowski C.R., and Swinehart G.L. Circulating immune complexes and nephropathy of cystic fibrosis. Hum Pathol 15 (1984) 244-247
15. Katz S.M., Krueger L.J., and Falkner B. Microscopic nephrocalcinosis in cystic fibrosis. N Engl J Med 5 (1988) 263-266
16. Melzi M.L., Costantini D., Giani M., Appiani A.C., and Giunta A.M. Severe nephropathy in three adolescents with cystic fibrosis. Arch Dis Child 12 (1991) 1444-1447
17. Laufer J., Augarten A., Szeinberg A., Rapoport J., Katzenelson D., and Yahav Y. Nephrotic syndrome and fibrillary glomerulonephritis. J Intern Med 1 (1997) 83-86
18. Soriano E., Fischman D., and Cheriyath P. Membranoproliferative glomerulonephritis in patients with cystic fibrosis: coincidence or comorbidity? A case series. South Med J 6 (2008) 641-645
19. Robson A.M., Tateishi S., Ingelfinger J.R., Strominger D.B., and Klahr S. Renal function in patients with cystic fibrosis. J Pediatr 1 (1971) 42-50
20. Roussey M., Dabadie A., Lennon A., Gie S., Legall E., and Le Marec B. Nephrotic syndrome in a child with cystic fibrosis. Acta Paediatr Scand 6 (1988) 920-921
21. Al-Shawwa B.A., and Rao A.R. Cystic fibrosis and renal disease: a case report. J Med Case Reports 1 (2007) 24-26
22. Persu A., Devuyst O., Lannoy N., Materne R., Brosnahan G., et al. CF gene and cystic fibrosis transmembrane conductance regulator expression in autosomal dominant polycystic kidney disease. J Am Soc Nephrol 12 (2000) 2285-2296
23. Xu N., Glockner J.F., Rossetti S., Babovich-Vuksanovic D., Harris P.C., and Torres V.E. Autosomal dominant polycystic kidney disease coexisting with cystic fibrosis. J Nephrol 4 (2006) 529-534
24. Stirati G., Antonelli M., Fofi C., Fierimonte S., and Pecci G. IgA nephropathy in cystic fibrosis. J Nephrol 1 (1999) 30-31
25. Bhatt N., and Bhatt N. IgA nephropathy in cystic fibrosis. Clin Nephrol 6 (2007) 403-404
26. D'Amico G., Imbasciati E., Barbiano Di Belgioioso G., Bertoli S., et al. Idiopathic IgA mesangial nephropathy. Clinical and histological study of 374 patients. Medicine (Baltimore) 1 (1985) 49-60
27. Endo Y., and Hara M. Glomerular IgA deposition in pulmonary diseases. Kidney Int 2 (1986) 557-562
28. Harland R.W., Becker C.G., Brandes J.C., Fritsche C., and Rosenzweig D.Y. Immunoglobulin A (IgA) immune complex pneumonitis in a patient with IgA nephropathy. Ann Intern Med 3 (1992) 220-222
29. Hernández J.I., Gómez-Román J., Rodrigo E., Olmos J.M., González-Vela C., et al. Bronchiolitis obliterans and IgA nephropathy. A new cause of pulmonary-renal syndrome. Am J Respir Crit Care Med 2 Pt 1 (1997) 665-668
30. Sedivá A., Bartůnková J., Kolárová I., Hrusák O., Vávrová V., Macek Jr. M., et al. Antineutrophil cytoplasmic autoantibodies (ANCA) in children with cystic fibrosis. J Autoimmun 11 2 (1998 Apr) 185-190
31. Dorlöchter L., Carlsson M., Olafsdottir E.J., Røksund O.D., Rosendahl K., and Fluge G. Antineutrophil cytoplasmatic antibodies and lung disease in cystic fibrosis. Cyst Fibros 3 (2004) 179-183
32. Finnegan M.J., Hinchcliffe J., Russell-Jones D., Neill S., Sheffield E., Jayne D., et al. Vasculitis complicating cystic fibrosis. Q J Med 267 (1989) 609-621
33. Garty B.Z., Scanlin T., Goldsmith D.P., and Grunstein M. Cutaneous manifestations of cystic fibrosis: possible role of cryoglobulins. Br J Dermatol 5 (1989) 655-658
34. Ristow S.C., Condemi J.J., Stuard I.D., Schwartz R.H., and Bryson M.F. Systemic amyloidosis in cystic fibrosis. Am J Dis Child 8 (1977) 886-888
35. Canciani M., Pederzini F., Mastella G., and Boccato P. Systemic amyloidosis in cystic fibrosis. Acta Paediatr Scand 4 (1985) 613-614
36. Castile R., Shwachman H., Travis W., Hadley C.A., Warwick W., and Missmahl H.P. Amyloidosis as a complication of cystic fibrosis. Am J Dis Child 7 (1985) 728-732
37. Travis W.D., Castile R., Vawter G., Shwachman H., Warwick W., Burke B.A., et al. Secondary (AA) amyloidosis in cystic fibrosis. A report of three cases. Am J Clin Pathol 4 (1986) 419-424
38. Gaffney K., Gibbons D., Keogh B., and FitzGerald M.X. Amyloidosis complicating cystic fibrosis. Thorax 9 (1993) 949-950
39. Guillot M., Drut-Desombre B., Amiour M., Aljazayri Z., Eckart P., Dominique S., et al. Secondary kidney amyloidosis and mucoviscidosis. Arch Pediatr 8 (1998) 884-886
40. McGlennen R.C., Burke B.A., and Dehner L.P. Systemic amyloidosis complicating cystic fibrosis. A retrospective pathologic study. Arch Pathol Lab Med 110 (1986) 879-888
41. Bontempini L., Ghimenton C., Colombari R., Malena M., Iuzzolino P., Canciani M., et al. Secondary amyloidosis and cystic fibrosis. A morphological and histochemical study of five cases. Histol Histopathol 4 (1987) 413-416
42. Mc Laughlin A.M., Crotty T.B., Egan J.J., Watson A.J., and Gallagher C.G. Amyloidosis in cystic fibrosis: a case series. J Cyst Fibros 1 (2006) 59-61
43. Skinner M., Pinnette A., Travis W.D., Shwachman H., and Cohen A.S. Isolation and sequence analysis of amyloid protein AA from a patient with cystic fibrosis. J Lab Clin Med 4 (1988) 413-417
44. Biberstein M., Wolf P., Pettross B., Fanestil D., and Vasquez M. Amyloidosis complicating cystic fibrosis. Am J Clin Pathol 5 (1983) 752-754
45. Rotellar C., Mazzoni M.J., Austin III H.A., Sabnis S.G., Kulczycki L., Rakowski T.A., et al. Chronic dialysis in a patient with cystic fibrosis. Nephron 2 (1989) 178-182
46. Kuwertz-Bröking E., Koch H.G., Schulze Everding A., Bulla M., Dworinczak B., Helmche U., et al. Colchicine for secondary nephropathic amyloidosis in cystic fibrosis. Lancet 8958 (1995) 1178-1179
47. Oppenheimer E.H. Glomerular lesions in cystic fibrosis: possible relation to diabetes mellitus, acquired cyanotic heart disease and cirrhosis of the liver. Johns Hopkins Med J 5 (1972) 351-366
48. Allen J.L. Progressive nephropathy in a patient with cystic fibrosis and diabetes. N Engl J Med 12 (1986) 764
49. Dolan Jr. T.F. Microangiopathy in a young adult with cystic fibrosis and diabetes mellitus. N Engl J Med 15 (1986) 991-992
50. Magryta C.J., Hennigar R., and Weatherly M. Pathological case of the month. Diabetic nephropathy in cystic fibrosis. Arch Pediatr Adolesc Med 12 (1999) 1307-1308
51. Dobson L., Stride A., Bingham C., Elworthy S., Sheldon C.D., and Hattersley A.T. Microalbuminuria as a screening tool in cystic fibrosis-related diabetes. Pediatr Pulmonol 2 (2005) 103-107
52. Westall G.P., Binder J., Kotsimbos T., Topliss D., Thomson N., Dowling J., and Wilson J.W. Nodular glomerulosclerosis in cystic fibrosis mimics diabetic nephropathy. Nephron Clin Pract 3 (2004) c70-c75
53. Chidekel A.S., and Dolan Jr. T.F. Cystic fibrosis and calcium oxalate nephrolithiasis. Yale J Biol Med 4 (1996) 317-321
54. Matthews L.A., Doershuk C.F., Stern R.C., and Resnick M.I. Urolithiasis and cystic fibrosis. J Urol 5 (1996) 1563-1564
55. Gutknecht D.R. Kidney stones and cystic fibrosis. Am J Med 1 (2001) 83
56. Perez-Brayfield M.R., Caplan D., Gatti J.M., Smith E.A., and Kirsch A.J. Metabolic risk factors for stone formation in patients with cystic fibrosis. J Urol 2 (2002) 480-484
57. Gibney E.M., and Goldfarb D.S. The association of nephrolithiasis with cystic fibrosis. Am J Kidney Dis 1 (2003) 1-11
58. Nathanson S., Frere F., Tassin E., and Foucaud P. Urolithiasis in cystic fibrosis. Arch Pediatr 9 (2003) 794-796
59. Terribile M., Capuano M., Cangiano G., Carnovale V., Ferrara P., Petrarulo M., et al. Factors increasing the risk for stone formation in adult patients with cystic fibrosis. Nephrol Dial Transplant 7 (2006) 1870-1875
60. Ozçelik U., Beşbaş N., Göçmen A., Akata D., Akhan O., Ozgüç M., et al. Hypercalciuria and nephrocalcinosis in cystic fibrosis patients. Turk J Pediatr 1 (2004) 22-27
61. Southern K.W. Acute renal failure in people with cystic fibrosis. Thorax 6 (2007) 472-473
62. Böhles H., and Michalk D. Is there a risk for kidney stone formation in cystic fibrosis?. Helv Paediatr Acta 3 (1982) 267-272
63. Bentur L., Kerem E., Couper R., Baumal R., Canny G., Durie P., et al. Renal calcium handling in cystic fibrosis: lack of evidence for a primary renal defect. J Pediatr 4 (1990) 556-560
64. Turner M.A., Goldwater D., and David T.J. Oxalate and calcium excretion in cystic fibrosis. Arch Dis Child 3 (2000) 244-247
65. Hanly J.G., McKenna M.J., Quigley C., Freaney R., Muldowney F.P., and Fitzgerald M.X. Hypovitaminosis D and response to supplementation in older patients with cystic fibrosis. Q J Med 219 (1985) 377-385
66. Donovan Jr. D.S., Papadopoulos A., Staron R.B., Addesso V., Schulman L., McGregor C., et al. Bone mass and vitamin D deficiency in adults with advanced cystic fibrosis lung disease. Am J Respir Crit Care Med 6 (1998) 1892-1899
67. Haworth C.S., Selby P.L., Webb A.K., Dodd M.E., Musson H., McL Niven R., et al. Low bone mineral density in adults with cystic fibrosis. Thorax 11 (1999) 961-967
68. Lark R.K., Lester G.E., Ontjes D.A., Blackwood A.D., Hollis B.W., Hensler M.M., and Aris R.M. Diminished and erratic absorption of ergocalciferol in adult cystic fibrosis patients. Am J Clin Nutr 3 (2001) 602-606
69. Rovner A.J., Stallings V.A., Schall J.I., Leonard M.B., and Zemel B.S. Vitamin D insufficiency in children, adolescents, and young adults with cystic fibrosis despite routine oral supplementation. Am J Clin Nutr 6 (2007) 1694-1699
70. Böhles H., Gebhardt B., Beeg T., Sewell A.C., Solem E., and Posselt G. Antibiotic treatment-induced tubular dysfunction as a risk factor for renal stone formation in cystic fibrosis. Helv Paediatr Acta 37 (1982) 267-272
71. Hoppe B., Hesse A., Brömme S., Rietschel E., and Michalk D. Urinary excretion substances in patients with cystic fibrosis: risk of urolithiasis?. Pediatr Nephrol 4 (1998) 275-279
72. Von der Heiden R., Balestra A.P., Bianchetti M.G., Casaulta Aebischer C., Mullis P.E., Lippuner K., et al. Which factors account for renal stone formation in cystic fibrosis?. Clin Nephrol 3 (2003) 160-163
73. Sidhu H., Hoppe B., Hesse A., Tenbrock K., Brömme S., Rietschel E., et al. Absence of Oxalobacter formigenes in cystic fibrosis patients: a risk factor for hyperoxaluria. Lancet 352 (1998) 1026-1029
74. Hoppe B., von Unruh G.E., Blank G., Rietschel E., Sidhu H., Laube N., et al. Absorptive hyperoxaluria leads to an increased risk for urolithiasis or nephrocalcinosis in cystic fibrosis. Am J Kidney Dis 3 (2005) 440-445
75. Orive Olondriz B., Elorz Lambarri J., and Vázquez Cordero C. Nephrolitiasis in a patient with cystic fibrosis. An Pediatr (Barc) 2 (2006) 154-157
76. Campieri C., Campieri M., Bertuzzi V., Swennen E., Matteuzzi D., Stefoni S., et al. Reduction of oxaluria after an oral course of lactic acid bacteria at high concentration. Kidney Int 3 (2001) 1097-1105
77. Lieske J.C., Goldfarb D.S., De Simone C., and Regnier C. Use of a probiotic to decrease enteric hyperoxaluria. Kidney Int 3 (2005) 1244-1249
78. Stapleton F.B., Kennedy J., Nousia-Arvanitakis S., and Linshaw M.A. Hyperuricosuria due to high-dose pancreatic extract therapy in cystic fibrosis. N Engl J Med 5 (1976) 246-248
79. Niessen K.H., and Wolf A. Studies on the cause of hyperuricosuria in cystic fibrosis patients. J Pediatr Gastroenterol Nutr 3 (1982) 349-354
80. Sack J., Blau H., Goldfarb D., Ben-Zaray S., and Katznelson D. Hyperuricosuria in cystic fibrosis patients treated with pancreatic enzyme supplements. Isr J Med Sci 6 (1980) 417-419
81. Nouisa-Arvanitakis S., Stapleton F.B., Linshaw M.A., and Kennedy J. Therapeutic approach to pancreatic extract-induced hyperuricosuria in cystic fibrosis. J Pediatr 2 (1977) 302-305
82. Wiersbitzky S., Ballke E.H., Wolf E., and Paul W. Uric acid serum concentrations in CF-children after pancreatic enzyme supplementation. Padiatr Grenzgeb 3 (1989) 171-173
83. Kraisinger M., Hochhaus G., Stecenko A., Bowser E., and Hendeles L. Clinical pharmacology of pancreatic enzymes in patients with cystic fibrosis and in vitro performance of microencapsulated formulations. J Clin Pharmacol 2 (1994) 158-166
84. Akbar A., Rees J.H., Nyamugunduru G., English M.W., Spencer D.A., and Weller P.H. Aminoglycoside-associated hypomagnesaemia in children with cystic fibrosis. Acta Paediatr 7 (1999) 783-785
85. Krebs N.F., Westcott J.E., Arnold T.D., Kluger B.M., Accurso F.J., Miller L.V., et al. Abnormalities in zinc homeostasis in young infants with cystic fibrosis. Pediatr Res 2 (2000) 256-261
86. Couper R., Bentur L., Kilbourn J.P., and Wolf P. Immunoreactive calmodulin in cystic fibrosis kidneys. Aust N Z J Med 5 (1993) 484-488
87. Goss C.H. Should we stop using intravenous gentamicin in patients with cystic fibrosis?. Thorax 6 (2008) 479-480
88. Bertenshaw C., Watson A.R., Lewis S., and Smyth A. Survey of acute renal failure in patients with cystic fibrosis in the UK. Thorax 6 (2007 Jun) 541-545
89. de Groot R., and Smith A.L. Antibiotic pharmacokinetics in cystic fibrosis. Differences and clinical significance. Clin Pharmacokinet 4 (1987) 228-253
90. Prandota J. Clinical pharmacology of antibiotics and other drugs in cystic fibrosis. Drugs 5 (1988) 542-578
91. Rey E., Tréluyer J.M., and Pons G. Drug disposition in cystic fibrosis. Clin Pharmacokinet 4 (1998) 313-329
92. Touw D.J. Clinical pharmacokinetics of antimicrobial drugs in cystic fibrosis. Pharm World Sci 4 (1998) 149-160
93. Tai A. Renal impairment following aminoglycoside therapy in cystic fibrosis. Thorax 10 (2008) 936
94. Woodland C., Blowey D., Ito S., Spino M., and Koren G. Hypothetical framework for enhanced renal tubular secretion of drugs in cystic fibrosis. Med Hypotheses 6 (1998) 489-491
95. Al-Aloul M., Miller H., Alapati S., Stockton P.A., Ledson M.J., and Walshaw M.J. Renal impairment in cystic fibrosis patients due to repeated intravenous aminoglycoside use. Pediatr Pulmonol 1 (2005) 15-20
96. Al-Aloul M., Miller H., Stockton P., Ledson M.J., and Walshaw M.J. Acute renal failure in CF patients chronically infected by the Liverpool epidemic Pseudomonas aeruginosa strain (LES). J Cyst Fibros 3 (2005) 197-201
97. Smyth A., Lewis S., Bertenshaw C., Choonara I., McGaw J., and Watson A. Case-control study of acute renal failure in patients with cystic fibrosis in the UK. Thorax 6 (2008) 532-535
98. Hoffmann I.M., Rubin B.K., Iskandar S.S., Schechter M.S., Nagaraj S.K., and Bitzan M.M. Acute renal failure in cystic fibrosis: association with inhaled tobramycin therapy. Pediatr Pulmonol 5 (2002) 375-377
99. Wood P.J., Ioannides-Demos L.L., Li S.C., Williams T.J., Hickey B., Spicer W.J., et al. Minimisation of aminoglycoside toxicity in patients with cystic fibrosis. Thorax 4 (1996) 369-373
100. Wood PJ, Ioannides-Demos LL, Li SC, Williams TJ, Hickey B, Spicer WJ, et al. Minimisation of aminoglycoside toxicity in patients with cystic fibrosis. Thorax 1996;4:369-73.
101. Drew J., Watson A.R., and Smyth A. Acute renal failure and cystic fibrosis. Arch Dis Child 7 (2003) 646
102. Kennedy S.E., Henry R.L., and Rosenberg A.R. Antibiotic-related renal failure and cystic fibrosis. J Paediatr Child Health 7 (2005) 382-383
103. Gerritsen W.R., Peters A., Henny F.C., and Brouwers J.R. Ciprofloxacin-induced nephrotoxicity. Nephrol Dial Transplant 5 (1987) 382-383
104. Bald M., Ratjen F., Nikolaizik W., and Wingen A.M. Ciprofloxacin-induced acute renal failure in a patient with cystic fibrosis. Pediatr Infect Dis J 3 (2001) 320-321
105. Moffett B.S., Rosenstein B.J., and Mogayzel Jr. P.J. Ciprofloxacin-induced renal insufficiency in cystic fibrosis. J Cyst Fibros 3 (2003) 152-154
106. Kovesi T.A., Swartz R., and MacDonald N. Transient renal failure due to simultaneous ibuprofen and aminoglycoside therapy in children with cystic fibrosis. N Engl J Med 1 (1998) 65-66
107. White D., Stiller K., and Roney F. The prevalence and severity of symptoms of incontinence in adult cystic fibrosis patients. Physiother Theor Pract 16 (2000) 35-42
108. Cornacchia M., Zenorini A., Perobelli S., Zanolla L., Mastella G., and Braggion C. Prevalence of urinary incontinence in women with cystic fibrosis. BJU Int 1 (2001) 44-48
109. Nixon G.M., Glazner J.A., Martin J.M., and Sawyer S.M. Urinary incontinence in female adolescents with cystic fibrosis. Pediatrics 2 Pt 1 (2002) e22
110. McVean R.J., Orr A., Webb A.K., Bradbury A., Kay L., Philips E., et al. Treatment of urinary incontinence in cystic fibrosis. J Cyst Fibros 4 (2003) 171-176
111. Moran F., Bradley J.M., Boyle L., and Elborn J.S. Incontinence in adult females with cystic fibrosis: a Northern Ireland survey. Int J Clin Pract 3 (2003) 182-183
112. Upadhyay D., and Jain M. Emphysematous cystitis and renal stones in cystic fibrosis. JAMA 16 (2004) 1953-1954
113. Schindler R., Radke C., Paul K., and Frei U. Renal problems after lung transplantation of cystic fibrosis patients. Nephrol Dial Transplant 7 (2001) 1324-1328
114. Lefaucheur C., Nochy D., Amrein C., Chevalier P., Guillemain R., et al. Renal histopathological lesions after lung transplantation in patients with cystic fibrosis. Am J Transplant 9 (2008) 1901-1910
115. Broekroelofs J., Navis G.J., Stegeman C.A., van der Bij W., de Boer W.J., de Zeeuw D., et al. Long-term renal outcome after lung transplantation is predicted by the 1-month postoperative renal function loss. Transplantation 8 (2000) 1624-1628
116. Ojo A.O., Held P.J., Port F.K., Wolfe R.A., Leichtman A.B., Young E.W., et al. Chronic renal failure after transplantation of a nonrenal organ. N Engl J Med 10 (2003) 931-940
117. Lefaucheur C., Hill G.S., Amrein C., Haymann J.P., Jacquot C., Glotz D., et al. Acute oxalate nephropathy: A new etiology for acute renal failure following nonrenal solid organ transplantation. Am J Transplant 10 (2006) 2516-2521